NORTHAMPTON, MA / ACCESSWIRE / January 5, 2023 / Quest Diagnostics
It's difficult to overestimate the toll that the COVID-19 pandemic has had on many of our nation's children-academically, socially, developmentally, and emotionally. Quest Diagnostics recognizes the critical role that daily in-school learning plays in helping our kids to overcome the very real challenges they faced with repeated lockdowns, school closings, and the limitations of remote learning.
In our commitment to supporting communities throughout the country, Quest has established multiple initiatives, including:
Quest's "Back to the Classroom" program as well as additional COVID-19 testing initiatives, are also helping college students, faculty, and staff safely return to and stay on campus.
View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com.
Contact Info:
Spokesperson: Quest Diagnostics
Website: https://www.3blmedia.com/profiles/quest-diagnostics
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$163.59 |
Daily Change: | -0.30 -0.18 |
Daily Volume: | 565,007 |
Market Cap: | US$18.260B |
October 23, 2024 October 22, 2024 October 15, 2024 September 18, 2024 August 26, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB